Is a Direct-to-Patient Access Model Viable For My Product?

Is a Direct-to-Patient Access Model Viable For My Product?
1. Is the therapeutic area and potential product conducive to a telehealth model?
2. Do I have access to or relationships with appropriate vendors? (i.e., Telehealth, Patient Support Services, Dispensing entities, etc.)
Required vendor services may include electronic benefits verification, affordability support, prescription routing, online ordering, claim adjudication, payment processing, shipping notifications, refill reminders, and prescription renewal
3. What options should be considered to establish a new patient access/dispensing model?
-
- Outsourced or Insourced services?
- Build or Acquire?
Manufacturers that may benefit from this strategic model include:
-
- Large organizations with an extensive portfolio of drugs
- Small organizations that may be forced to engage major stakeholders (Wholesalers, PBMs, Retail Chains, etc.) at non-sustainable rates to secure commercial success
- Any company with a pharmacy benefit product(s) that PBMs/Payers are closely monitoring and tightly managing
Learn more about Team Archbow and the methodology that matters most to successful programs, and contact us today for assistance with your strategic and tactical patient support and distribution needs. Our team works seamlessly to align even the most complicated patient, product, and reimbursement journeys.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
Fair Market Value vs. Current Market Leverage
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Archbow Consulting Strengthens Leadership Team with Key Promotions
Strategic appointments reflect Archbow’s continued growth and commitment to delivering exceptional value to its clients.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|